Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SCD | O00767 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL959108 | 1.00 | KCNH2 (0.34) | KCNH2TSHRTHRBALDH1A1ACHE | |
| SCHEMBL7060405 | 1.00 | KCNH2 (0.34) | KCNH2TSHRTHRBALDH1A1ACHE | |
| SCHEMBL8337997 | 1.00 | KCNH2 (0.34) | KCNH2TSHRTHRBALDH1A1ACHE | |
| SCHEMBL7056733 | 1.00 | KCNH2 (0.34) | KCNH2TSHRTHRBALDH1A1ACHE | |
| SCHEMBL7061452 | 1.00 | KCNH2 (0.34) | KCNH2TSHRTHRBALDH1A1ACHE | |
| SCHEMBL7058385 | 1.00 | KCNH2 (0.34) | KCNH2TSHRTHRBALDH1A1ACHE | |
| SCHEMBL2493950 | 1.00 | KCNH2 (0.34) | KCNH2TSHRTHRBALDH1A1ACHE | |
| SCHEMBL7206068 | 1.00 | KCNH2 (0.34) | KCNH2TSHRTHRBALDH1A1ACHE | |
| SCHEMBL7056094 | 1.00 | KCNH2 (0.34) | KCNH2TSHRTHRBALDH1A1ACHE | |
| SCHEMBL960613 | 1.00 | KCNH2 (0.34) | KCNH2TSHRTHRBALDH1A1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019034597-A1 | FORCE-RESPONSIVE POLYMERSOMES AND NANOREACTORS; PROCESSES UTILIZING THE SAME | ADOLPHE MERKLE INSTITUTE, UNIVERSITY OF FRIBOURG (CH) | 2019-02-21 | — | — | WO | claimed |
| CN-1662354-A | Smoothing method for layered deposition modeling | STRATASYS INC (US) | 2005-08-31 | — | — | CN | claimed |
| US-20260144748-A1 | POLYOL-BASED MULTI-FUNCTIONAL COMPOUNDS FOR MEDICAL APPLICATIONS AND HYDROGELS FORMED FROM SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260144900-A1 | IN VIVO CROSSLINKABLE HYDROGELS WITH GOLD NANOPARTICLES FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| WO-2026101973-A1 | IODINATED MULTI-FUNCTIONAL COMPOUNDS WITH ENHANCED HYDROLYTIC STABILITY IN RADIOPAQUE HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-4739362-A1 | CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | Boston Scientific Scimed, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739355-A1 | CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | Boston Scientific Scimed, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260125517-A1 | IODINATED MULTI-FUNCTIONAL COMPOUNDS WITH ENHANCED HYDROLYTIC STABILITY IN RADIOPAQUE HYDROGELS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| WO-2026090380-A1 | BIORESORBABLE CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026090120-A1 | HIGH MOLECULAR WEIGHT MULTI-ARM POLYMERS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026090138-A1 | ETHER-CONTAINING RADIOPAQUE POLYAMINO CROSSLINKERS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20040242816-A1 | Method for the production of a polymer conversion product by means of metal catalysis | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-02 | — | — | US | disclosed |
| EP-1445282-A1 | RESIN COMPOSITION AND MOLDED ARTICLE FILM AND FIBER EACH COMPRISING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2004-08-11 | — | — | EP | disclosed |
| EP-1440095-A1 | METHOD FOR THE PRODUCTION OF A POLYMER CONVERSION PRODUCT BY MEANS OF METAL CATALYSIS | BASF AKTIENGESELLSCHAFT (DE) | 2004-07-28 | — | — | EP | disclosed |
| WO-2003020774-A1 | METHOD FOR THE PRODUCTION OF A POLYMER CONVERSION PRODUCT BY MEANS OF METAL CATALYSIS | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-13 | — | — | WO | disclosed |
| US-6210783-B1 | COMPRISED OF SUPPORTING SUBSTRATE, A HEAT DISSIPATING COATING LAYER IN CONTACT WITH SUBSTRATE, WHEREIN COATING IS COMPRISED OF A HEAT DISSIPATING BINDER, AN ANTISTATIC COMPOUND, AN INK RECEIVER COATING COMPRISING BINDER, OXAZOLINE COMPOUND | XEROX CORPORATION | 2001-04-03 | — | — | US | disclosed |
| US-5252407-A | Containing cyclic iminoether compound | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-10-12 | — | — | US | disclosed |
| EP-0335980-B1 | RUBBER COMPOSITE | Takeda Chemical Industries, Ltd. (JP) | 1993-01-27 | — | — | EP | disclosed |
| EP-0335980-A1 | RUBBER COMPOSITE | Takeda Chemical Industries, Ltd. (JP) | 1989-10-11 | — | — | EP | disclosed |
| US-4540747-A | POLYOXAZOLINES AND OXAZINES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1985-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144900-A1 | IN VIVO CROSSLINKABLE HYDROGELS WITH GOLD NANOPARTICLES FOR MEDICAL APPLICATIONS | KLK3, BPHL, BRDT | KCNH2 4554/4885TSHR 2349/4885THRB 3065/4885 |
| US-20260125517-A1 | IODINATED MULTI-FUNCTIONAL COMPOUNDS WITH ENHANCED HYDROLYTIC STABILITY IN RADIOPAQUE HYDROGELS | MMP1, ILK, MMP13 | KCNH2 3807/4885TSHR 857/4885THRB 2340/4885 |
| US-20260144748-A1 | POLYOL-BASED MULTI-FUNCTIONAL COMPOUNDS FOR MEDICAL APPLICATIONS AND HYDROGELS FORMED FROM SAME | CD44, PAM, PLOD3 | KCNH2 4608/4885TSHR 2551/4885THRB 4020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.